RBC Capital Maintains Outperform on HCA Healthcare, Lowers Price Target to $435

Benzinga · 3d ago
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the price target from $534 to $435.